Patents by Inventor Sheikh Riazuddin

Sheikh Riazuddin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
    Patent number: 8809354
    Abstract: Surprising antiviral activity of 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone (Compound 1) was reported in the treatment or prevention of viral infections, particularly in combination with other antiviral agents such as interferon and/or ribavarin.
    Type: Grant
    Filed: December 31, 2011
    Date of Patent: August 19, 2014
    Inventors: Sheikh Riazuddin, Osman Ali, Usman Ashfaq, Shaheen N. Khan, Javed Akram, Atta-ur Rahman, M. Iqbal Choudhary, Khalid M. Khan, Zulfiqar Ali Khan
  • Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering
    Patent number: 8530167
    Abstract: The allelic variants or mutations in three genes: GNPTAB, GNPTG and NAGPA, that correlate with stuttering in humans, as well as the encoded mutated polypeptides and related vectors, host cells, antibodies, antibody-producing cell lines and methods of diagnosing, prognosticating and treating stuttering are provided.
    Type: Grant
    Filed: February 8, 2010
    Date of Patent: September 10, 2013
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Centre of Excellence in Molecular Biology Together With All Allied Components, University of Punjab
    Inventors: Dennis T. Drayna, Changsoo Paul Kang, Sheikh Riazuddin
  • 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
    Publication number: 20130171101
    Abstract: Surprising antiviral activity of 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone (Compound 1) was reported in the treatment or prevention of viral infections, particularly in combination with other antiviral agents such as interferon and/or ribavarin.
    Type: Application
    Filed: December 31, 2011
    Publication date: July 4, 2013
    Inventors: Sheikh Riazuddin, Osman Ali, Usman Ashfaq, Shaheen N. Khan, Javed Akram, Atta-ur Rahman, M. Iqbal Choudhary, Khalid M. Khan, Zulfiqa Ali Khan
  • DIAGNOSTIC AND THERAPEUTIC USES OF GNPTAB, GNPTG, AND NAGPA IN STUTTERING
    Publication number: 20110313029
    Abstract: The allelic variants or mutations in three genes: GNPTAB, GNPTG and NAGPA, that correlate with stuttering in humans, as well as the encoded mutated polypeptides and related vectors, host cells, antibodies, antibody-producing cell lines and methods of diagnosing, prognosticating and treating stuttering are provided.
    Type: Application
    Filed: February 8, 2010
    Publication date: December 22, 2011
    Applicants: Centre of Excellence in Molecular Biology Together with all Allied Components, University of Punjab, The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Dennis T. Drayna, Changsoo Paul Kang, Sheikh Riazuddin
  • Heat-Tolerant Cotton Plant Containing Multiple Transgenes
    Publication number: 20100186104
    Abstract: The present invention provides methods to genetically transform cotton plant, Gossypium hirsutum, a heat-tolerant cotton variety to impart resistance to insect damage and to make stable hybrid variety for commercial use.
    Type: Application
    Filed: January 21, 2009
    Publication date: July 22, 2010
    Applicant: National Center of Excellence in Molecular Biology, Punjab University
    Inventors: Sheikh Riazuddin, Tayyab Hussain
  • Bacillus thuringiensis isolates active against sucking insects
    Patent number: 6150156
    Abstract: The subject invention concerns novel Bacillus thuringiensis strains containing parasporal proteins with pesticidal properties against whitefly, aphid, jassid, and possibly other sucking insects of agronomic importance, and peptide sequences to these proteins that can be used to obtain structural genes. The spores or crystals of these microbes, or mutants thereof, are useful to control hymenopteran pests in various environments. The genes of the invention can be used to transform various hosts wherein the novel toxic proteins can be expressed.
    Type: Grant
    Filed: February 10, 1998
    Date of Patent: November 21, 2000
    Assignee: Calgene, Inc.
    Inventor: Sheikh Riazuddin